Safety of Concurrent Administration of Ozanimod and Serotonergic Antidepressants in Patients with Relapsing Multiple Sclerosis

被引：0
|
作者：
Naismith, R. T. [1 ]
Cohen, J. A. [2 ]
Bar-Or, A. [3 ,4 ]
Comi, G. [5 ]
Selmaj, K. W. [6 ,7 ]
Hartung, H. [8 ]
Sheffield, J. K. [9 ]
Minton, N. [9 ]
Gleichmann, M. [9 ]
Liu, H. [9 ]
Riolo, J. [9 ]
Silva, D. [9 ]
Cree, B. A. [10 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] Cleveland Clin, Mellen Ctr MS Treatment & Res, Cleveland, OH 44106 USA
[3] Univ Penn, Perelman Sch Med, Ctr Neuroinflammat & Expt Therapeut, Philadelphia, PA 19104 USA
[4] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA
[5] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Dept Neurol, Milan, Italy
[6] Ctr Neurol, Lodz, Poland
[7] Univ Warmia & Mazury, Dept Neurol, Coll Med, Olsztyn, Poland
[8] Heinrich Heine Univ, Fac Med, Dept Neurol, Dusseldorf, Germany
[9] Bristol Myers Squibb, Princeton, NJ USA
[10] Univ Calif San Francisco, Dept Neurol, Weill Inst Neurosci, San Francisco, CA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 1_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P080
引用
收藏
页码：53 / 54
页数：2
相关论文
共 50 条
  • [41] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Craveiro, L.
    Hughes, R.
    Prajapati, K.
    Koendgen, H.
    Pradhan, A.
    Wolinsky, J. S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 331 - 331
  • [42] Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, Stephen L.
    Kappos, Ludwig
    Montalban, Xavier
    Guittari, Carol-Jean
    Koendgen, Harold
    Li, Carrie
    Marcillat, Carole
    Wormser, David
    Wolinsky, Jerry
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP13 - NP13
  • [43] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Hughes, R.
    McNamara, J.
    Pradhan, A.
    Wormser, D.
    Koendgen, H.
    Wolinsky, J. S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 239 - 239
  • [44] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary Progressive Multiple Sclerosis
    Kappos, Ludwig
    Hauser, Stephen
    Montalban, Xavier
    Buffels, Regine
    Chin, Peter
    Li, Carrie
    Mortensen, Deborah
    Napieralski, Julie
    Van Beek, Johan
    Wormser, David
    Wolinsky, Jerry
    NEUROLOGY, 2017, 88
  • [45] Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S.
    Kappos, L.
    Montalban, X.
    Craveiro, L.
    Hughes, R.
    McNamara, J.
    Pradhan, A.
    Wormser, D.
    Koendgen, H.
    Wolinsky, J. S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [46] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, Stephen L.
    Kappos, Ludwig
    Montalban, Xavier
    Hughes, Richard
    McNamara, John
    Pradhan, Ashish
    Wormser, David
    Koendgen, Harold
    Wolinsky, Jerry S.
    NEUROLOGY, 2019, 92 (15)
  • [47] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Hughes, R.
    Koendgen, H.
    McNamara, J.
    Pradhan, A.
    Wormser, D.
    Wolinsky, J. S.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 697 - 698
  • [48] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Chognot, C.
    Jessop, N.
    Pradhan, A.
    Prajapati, K.
    Wolinsky, J. S.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 607 - 608
  • [49] Long-term cardiac safety of ozanimod in phase 3 clinical program of Ulcerative Colitis and relapsing multiple sclerosis
    Armuzzi, A.
    Cross, R. K.
    Lichtenstein, G.
    Calkwood, J.
    Pai, A.
    Pondel, M.
    Ahmad, H. A.
    Charles, L.
    Elegbe, A.
    Petersen, A.
    Sheffield, J. K.
    Javed, A.
    Hou, J.
    Regueiro, M.
    Wolf, D. C.
    Long, M.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I094 - I095
  • [50] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, Stephen L.
    Kappos, Ludwig
    Montalban, Xavier
    Chognot, Cathy
    Jessop, Nikki
    Pradhan, Ashish
    Prajapati, Kalpesh
    Wolinsky, Jerry S.
    NEUROLOGY, 2021, 96 (15)
12345